Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Back to Library
Vial

Peptide Library / Detail

N-Acetyl Selank

Synthetic heptapeptide anxiolyticResearch use only

Half-life

6-8 hours

Delivery

Subcutaneous injection or intranasal spray

Dosage

Research Use Only

All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.

Purchase

No purchase links available

Description

N-Acetyl Selank is an acetylated derivative of Selank, a synthetic peptide based on the immunomodulatory peptide tuftsin. The N-acetylation modification extends the peptide's half-life and enhances its stability compared to standard Selank. It is primarily researched for its anxiolytic, nootropic, and mood-regulating properties without sedative or addiction potential.

Usage

Research protocols typically employ 250-1000 mcg administered 1-3 times daily via subcutaneous injection or intranasal spray. Many studies use a 14-30 day cycle with evaluation periods. Administration is often conducted in the morning or early afternoon to support cognitive function throughout the day.

Mechanism of Action

N-Acetyl Selank modulates brain-derived neurotrophic factor (BDNF) expression and influences the enkephalin system to regulate anxiety responses. It affects the balance of serotonin and dopamine while stabilizing IL-6 and other inflammatory markers. The N-acetyl group protects against enzymatic degradation, allowing for enhanced bioavailability and extended activity at GABAergic and monoaminergic receptor sites.

Benefits(7)

  • Reduced anxiety without sedation or cognitive impairment
  • Enhanced focus and mental clarity
  • Improved stress resilience and emotional stability
  • Neuroprotective effects and BDNF upregulation
  • Enhanced learning and memory consolidation
  • Mood stabilization and reduced depression symptoms
  • Immunomodulatory effects supporting balanced immune response

Side Effects(6)

  • Mild headache in initial dosing period
  • Transient fatigue or drowsiness at higher doses
  • Nasal irritation with intranasal administration
  • Injection site reactions with subcutaneous use
  • Rare gastrointestinal discomfort
  • Possible initial adjustment period with mood changes